FCM
Frontier Capital Management Portfolio holdings
AUM
$10.8B
1-Year Return
32.36%
This Quarter Return
+8.99%
1 Year Return
+32.36%
3 Year Return
+147.77%
5 Year Return
+285.35%
10 Year Return
+891.74%
AUM
$13.7B
AUM Growth
+$435M
(+3.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-3.43%
Top 10 Holdings %
Top 10 Hldgs %
15.96%
Holding
301
New
25
Increased
112
Reduced
147
Closed
17
Top Buys
| 1 |
NovoCure
NVCR
|
$79M |
| 2 |
SGFY
Signify Health, Inc.
SGFY
|
$68.7M |
| 3 |
Natera
NTRA
|
$63.1M |
| 4 |
Vimeo
VMEO
|
$54.7M |
| 5 |
Leslie's
LESL
|
$53.7M |
Top Sells
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
$213M |
| 2 |
Magnite
MGNI
|
$140M |
| 3 |
Caesars Entertainment
CZR
|
$91.8M |
| 4 |
IAC Inc
IAC
|
$82.5M |
| 5 |
Vulcan Materials
VMC
|
$59.5M |
Sector Composition
| 1 | Technology | 22.52% |
| 2 | Consumer Discretionary | 19.1% |
| 3 | Healthcare | 18.14% |
| 4 | Industrials | 15.02% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Amphastar Pharmaceuticals
AMPH
$1.37B
| $3.73M | 0.03% |
+184,979
| New | +$3.73M |
|
|
TVRD
277
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $3.58M | 0.03% |
6,975
-911
| -12% | -$468K |
|
278
Nektar Therapeutics
NKTR
$764M
| $2.01M | 0.01% |
7,791
-21,937
| -74% | -$5.65M |
|
|
NSTG
279
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.61M | 0.01% |
24,772
-159,956
| -87% | -$10.4M |
|
280
Revolution Medicines
RVMD
$7.57B
| $694K | 0.01% |
21,853
-649
| -3% | -$20.6K |
|
281
Teradyne
TER
$19.1B
| $411K | ﹤0.01% |
3,069
-91
| -3% | -$12.2K |
|
282
Five Below
FIVE
$8.46B
| $410K | ﹤0.01% |
2,120
-62
| -3% | -$12K |
|
283
Paylocity
PCTY
$9.62B
| $307K | ﹤0.01% |
1,609
-49
| -3% | -$9.35K |
|
284
Insmed
INSM
$30.7B
| $215K | ﹤0.01% |
7,563
-113,846
| -94% | -$3.24M |
|
285
ADC Therapeutics
ADCT
$398M
| – | – |
-78,137
| Closed | -$1.91M |
|
286
Boot Barn
BOOT
$5.58B
| – | – |
-126,815
| Closed | -$7.9M |
|
287
Century Communities
CCS
$2.07B
| – | – |
-88,637
| Closed | -$5.35M |
|
288
Cousins Properties
CUZ
$4.95B
| – | – |
-201,358
| Closed | -$7.12M |
|
289
Darling Ingredients
DAR
$5.07B
| – | – |
-194,383
| Closed | -$14.3M |
|
290
Denali Therapeutics
DNLI
$2.26B
| – | – |
-7,742
| Closed | -$442K |
|
291
Golar LNG
GLNG
$4.52B
| – | – |
-174,767
| Closed | -$1.79M |
|
292
James River Group
JRVR
$249M
| – | – |
-846,662
| Closed | -$38.6M |
|
|
293
Magnite
MGNI
$3.54B
| – | – |
-3,373,124
| Closed | -$140M |
|
294
MGP Ingredients
MGPI
$622M
| – | – |
-96,661
| Closed | -$5.72M |
|
295
MYR Group
MYRG
$2.79B
| – | – |
-191,274
| Closed | -$13.7M |
|
296
PRA Group
PRAA
$671M
| – | – |
-200,980
| Closed | -$7.45M |
|
|
297
Vulcan Materials
VMC
$39B
| – | – |
-352,873
| Closed | -$59.5M |
|
|
NUVA
298
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-407,544
| Closed | -$26.7M |
|
|
CSII
299
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – |
-193,708
| Closed | -$7.43M |
|
|
PLAN
300
DELISTED
Anaplan, Inc.
PLAN
| – | – |
-63,906
| Closed | -$3.44M |
|